Literature DB >> 25208065

Lung cancer.

Herb Brody.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25208065     DOI： 10.1038/513S1a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  38 in total

1.  Knockdown of TOR signaling pathway regulator suppresses cell migration and invasion in non-small cell lung cancer via the regulation of epithelial-to-mesenchymal transition.

Authors:  Xiang Xu; Huangkai Zhu; Minglei Yang; Enkuo Zheng; Yinjie Zhou; Junjun Ni; Rui Li; Zhenhua Yang; Ti He; Guofang Zhao
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447

2.  Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.

Authors:  Daye Zhang; Yongxiang Zhang; Zeyuan Cai; Ying Tu; Zhansong Hu
Journal:  Exp Ther Med       Date:  2019-11-21       Impact factor: 2.447

3.  Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer.

Authors:  Cuixia Cai; Rong Shi; Yuan Gao; Jun Zeng; Min Wei; Handuo Wang; Wenling Zheng; Wenli Ma
Journal:  Oncol Lett       Date:  2015-09-23       Impact factor: 2.967

4.  Contrast-enhanced ultrasound with a novel nanoparticle contrast agent for clinical diagnosis in patients with non-small cell lung cancer.

Authors:  Na Li; Lu Han; Hui Jing
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

5.  Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma.

Authors:  Rong Qiao; Runbo Zhong; Chunlan Liu; Feifei Di; Zheng Zhang; Ling Wang; Tian Xu; Yue Wang; Liping Dai; Wanjian Gu; Baohui Han; Rongxi Yang
Journal:  Genes Genomics       Date:  2021-11-16       Impact factor: 1.839

6.  Comprehensive Analysis of Expression and Prognostic Value of GATAs in Lung Cancer.

Authors:  Chengwu Gong; Yun Fan; Xueliang Zhou; Songqing Lai; Lijun Wang; Jichun Liu
Journal:  J Cancer       Date:  2021-05-05       Impact factor: 4.207

7.  MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer.

Authors:  Chuanqing Jing; Rong Fu; Can Wang; Xiurong Li; Wei Zhang
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989

8.  Meiotic nuclear divisions 1 (MND1) fuels cell cycle progression by activating a KLF6/E2F1 positive feedback loop in lung adenocarcinoma.

Authors:  Quanli Zhang; Run Shi; Yongkang Bai; Lijuan Meng; Jingwen Hu; Hongyu Zhu; Tongyan Liu; Xiaomeng De; Siwei Wang; Jie Wang; Lin Xu; Guoren Zhou; Rong Yin
Journal:  Cancer Commun (Lond)       Date:  2021-03-18

9.  An Approach to Improve the Performance of PM Forecasters.

Authors:  Paulo S G de Mattos Neto; George D C Cavalcanti; Francisco Madeiro; Tiago A E Ferreira
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

10.  circ_0005962 functions as an oncogene to aggravate NSCLC progression.

Authors:  Zhihong Zhang; Zhenxiu Shan; Rubin Chen; Xiaorong Peng; Bin Xu; Liang Xiao; Guofei Zhang
Journal:  Open Med (Wars)       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.